Baird Financial Group, Inc. - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 67 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$320,000
+31.1%
57,283
+9.9%
0.00%0.0%
Q4 2021$244,000
-30.9%
52,129
-8.8%
0.00%0.0%
Q3 2021$353,000
-9.5%
57,130
-3.5%
0.00%0.0%
Q2 2021$390,000
-0.3%
59,185
+10.8%
0.00%0.0%
Q1 2021$391,00053,4320.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,556,600$11,990,0003.66%
Worth Venture Partners, LLC 585,168$2,744,0001.36%
Birchview Capital, LP 140,000$657,0000.42%
NEA Management Company, LLC 3,952,958$18,539,0000.38%
J. Goldman & Co LP 1,220,758$5,725,0000.32%
Opaleye Management Inc. 263,400$1,235,0000.26%
Sender Co & Partners, Inc. 92,026$432,0000.22%
X-Square Capital, LLC 92,283$433,0000.22%
XTX Topco Ltd 18,128$85,0000.05%
PURA VIDA INVESTMENTS, LLC 123,416$579,0000.02%
View complete list of AVEO PHARMACEUTICALS INC shareholders